Epilepsy Monitoring Devices Market Dynamics and Latest Technological Developments

 


This report aims to provide detailed insights into the global epilepsy monitoring devices market. It provides valuable information on the type, procedure, application, and region in the market. Furthermore, the information for these segments, by region, is also presented in this report. Leading players in the market are profiled to study their product offerings and understand the strategies undertaken by them to be competitive in this market.

Expected Revenue Growth Analysis:

[187 Pages Report] The global epilepsy monitoring devices market is projected to reach USD 615 million by 2026 from USD 489 million in 2021, at a CAGR of 4.7%.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=62758189

Key Factors Driving Epilepsy Monitoring Devices Market Growth:

The growth in the market is mainly driven by the increasing incidence and prevalence of epilepsy, growing preference for ambulatory healthcare and increasing use of wearables, growing demand for continuous monitoring, and the rising awareness of neurodegenerative diseases, including epilepsy.

Increasing demand for non-invasive and minimally invasive devices

Invasive monitoring is a complex, painful, and risky process, as it involves direct intervention with sensitive brain tissue. Doctors and patients, therefore, show a high inclination toward the use of non-invasive or minimally invasive epilepsy monitoring devices which in turn driving growth of epilepsy monitoring devices market.

Several government initiatives are focused on the development of novel and innovative devices, such as the BRAIN initiative launched in the US in April 2013 for encouraging R&D related to the functioning of the brain. Advanced Research Projects Activity (IARPA) joined the BRAIN initiative for the development of non-invasive neural intervention devices for optimizing reasoning and problem-solving.

By product segment, the conventional devices segment accounted for the largest market share of epilepsy monitoring devices market in 2020

Among the products segment, the conventional devices segment accounted for the largest market share in 2020. The large share of this segment is attributed to the rising awareness of neurodegenerative diseases including epilepsy.  

In the conventional devices segment, monitoring devices contributed the largest share. The growth of this segment is driven by the increasing demand for continuous monitoring and minimally invasive and non-invasive devices.

Increasing incidence and prevalence of epilepsy

According to the WHO, an estimated five million people around the world are diagnosed with epilepsy each year. In high-income countries, there are estimated to be 49 per 100,000 people diagnosed with epilepsy each year. In low- and middle-income countries, this figure can be as high as 139 per 100,000. This is likely due to the increased risk of endemic conditions such as malaria or neurocysticercosis, the higher incidence of road traffic injuries and birth-related injuries, variations in medical infrastructure, and the availability of preventive health programs and accessible care (in high-income countries).

Growth and Demand Analysis of Epilepsy Monitoring Devices Market in North America and APAC Region:

North America accounted for the largest share of the market in 2020. The high incidence of neurological disorders, a growing number of clinical trials for epilepsy monitoring devices, and a large number of end users in the US are the major factor contributing to this.

The Asia Pacific market is projected to grow at the highest CAGR during the forecast period. The high growth in this regional market can be attributed to rising medical tourism, the implementation of new ICT guidelines in Japan, investments, and reforms to modernize China’s healthcare infrastructure, the presence of a large target patient population (coupled with the rapidly growing geriatric population, especially in Japan and China), growing awareness about epilepsy, and the increasing healthcare expenditure in emerging APAC countries such as China and India.

Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=62758189

Key Players:

The major players in the global epilepsy monitoring devices market are Natus Medical, Inc. (US), Compumedics Limited (Australia), Empatica, Inc. (US), The Magstim Co. Ltd. (UK), Nihon Kohden Corporation (Japan), Medtronic Plc (Ireland), Masimo Corporation (US), Boston Scientific Corporation (US), Drägerwerk AG & Co. KGaA (Germany), mjn Neuroserveis S.L. (Spain), Abbott Laboratories, Inc. (US), LivAssured B.V. (Netherlands), BioSerenity (France), Aleva Neurotherapeutics (Switzerland), Medpage, Ltd. (UK), Neurosoft (Russia), Advanced Brain Monitoring (US), Lifelines Neuro Company, LLC (US)


Comments

Post a Comment

Popular posts from this blog

Mass Spectrometry Market - Current and Future Perspectives 2025

Image
  What This Report Will Provide? This study involved four major activities in estimating the current size of the mass spectrometry market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the size of segments and subsegments. Expected Revenue Growth: [190 Pages Report]  The mass spectrometry market size is expected to grow from an estimated USD 4.1 billion in 2020 to USD 5.6 billion by 2025, at a CAGR of 6.5%. Major Growth Boosters: Growth in the mass spectrometry market is primarily driven by factors such as government initiatives for pollution control and environmental testing...
Read more

Home Healthcare Market Dynamics and Latest Developments

Image
  This report aims to provide detailed insights into the global home healthcare market . It provides valuable information on the type, procedure, application, and region in the market. Furthermore, the information for these segments, by region, is also presented in this report. Leading players in the market are profiled to study their product offerings and understand the strategies undertaken by them to be competitive in this market. Expected Revenue Growth: The Home Healthcare Market is projected to reach  USD 298.2 billion  by 2026 from  USD 198.9 billion  in 2021, at a CAGR of 8.4% during the forecast period. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=696 Key Factors Driving Market Growth: The Rapid growth in the elderly population, the rising incidence of chronic diseases, the growing need for cost-effective healthcare delivery due to the increasing healthcare costs, and technological advancements of home ...
Read more

Pain Management Devices Market Growth, Trends, Size, Share, Industry Demand, Global Analysis

Image
Key Factors Driving Pain Management Devices Market Growth: Pain management devices are used to manage chronic and acute pain in patients suffering from various types of disease conditions, such as cancer, neurological disorders, and musculoskeletal disorders, among others. These devices restore the ability to do everyday activities, decrease the need for oral pain medications, and improve the quality of life of patients suffering from these conditions. Revenue Growth Analysis: [249 Pages Report]  The global pain management devices market is projected to reach USD 3.3 billion by 2026 from USD 2.2 billion in 2021, at a CAGR of 8.6% The study involved four major activities in estimating the current size of the Pain Management Devices Market . Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research...
Read more